Jonathan W Haskins
Overview
Explore the profile of Jonathan W Haskins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haskins J, Spizzoucco F, Walker B
J Exp Zool A Ecol Integr Physiol
. 2018 Jan;
327(6):358-365.
PMID: 29356457
Glucocorticoids modify metabolism and other physiological processes in order to mount an appropriate response to stress. This stress response is affected by a combination of seasonal changes, life-history events, and...
2.
Haskins J, Zhang S, Means R, Kelleher J, Cline G, Canfran-Duque A, et al.
Sci Signal
. 2015 Nov;
8(401):ra111.
PMID: 26535009
Cholesterol is a lipid that is critical for steroid hormone production and the integrity of cellular membranes, and, as such, it is essential for cell growth. The epidermal growth factor...
3.
Wali V, Gilmore-Hebert M, Mamillapalli R, Haskins J, Kurppa K, Elenius K, et al.
Breast Cancer Res
. 2014 Dec;
16(6):501.
PMID: 25516216
Introduction: Human Epidermal Growth Factor Receptor (ERBB4/HER4) belongs to the Epidermal Growth Factor receptor/ERBB family of receptor tyrosine kinases. While ERBB1, ERBB2 and ERBB3 are often overexpressed or activated in...
4.
Haskins J, Nguyen D, Stern D
Sci Signal
. 2014 Dec;
7(355):ra116.
PMID: 25492965
The receptor tyrosine kinase ERBB4, a member of the epidermal growth factor receptor (EGFR) family, is unusual in that ERBB4 can undergo intramembrane proteolysis, releasing a soluble intracellular domain (ICD)...
5.
Wali V, Haskins J, Gilmore-Hebert M, Platt J, Liu Z, Stern D
Mol Cancer Res
. 2014 May;
12(8):1140-55.
PMID: 24829397
Unlabelled: Associations of ErbB4 (ERBB4/HER4), the fourth member of the EGFR family, with cancer are variable, possibly as a result of structural diversity of this receptor. There are multiple structural...
6.
Breindel J, Haskins J, Cowell E, Zhao M, Nguyen D, Stern D
Cancer Res
. 2013 Jun;
73(16):5053-65.
PMID: 23794705
MET amplification as a mechanism of acquired resistance to EGF receptor (EGFR)-targeted therapies in non-small cell lung carcinoma (NSCLC) led to investigation of novel combinations of EGFR and MET kinase...
7.
Held M, Langdon C, Platt J, Graham-Steed T, Liu Z, Chakraborty A, et al.
Cancer Discov
. 2012 Dec;
3(1):52-67.
PMID: 23239741
Unlabelled: Resistance and partial responses to targeted monotherapy are major obstacles in cancer treatment. Systematic approaches to identify efficacious drug combinations for cancer are not well established, especially in the...